Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Bronchiectasis

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Major haemoptysis, severe hypoxaemia, sepsis, exhaustion or rapidly worsening respiratory failure requires same-day hospital care. Stabilise first, send sputum and blood cultures when this does not delay treatment, involve respiratory and critical-care teams, and obtain urgent interventional-radiology and thoracic-surgical input for ongoing significant haemoptysis. Do not ask the patient to perform forceful airway clearance while bleeding is active without specialist direction.

Synopsis

Recognise the clinical syndrome, confirm bronchial dilatation on thin-section CT, complete a cause-changing aetiology screen, and organise airway clearance, vaccination, rehabilitation and longitudinal review.

  • Bronchiectasis is a clinical-radiological syndrome: permanent bronchial dilatation on thin-section CT must be interpreted with chronic cough, sputum, infection, haemoptysis or another compatible presentation.
  • Suspect it with persistent mucopurulent sputum, recurrent lower-respiratory infections or unexplained haemoptysis, especially with rheumatoid disease, inflammatory bowel disease, childhood infection or chronic rhinosinusitis.
  • A baseline cause panel matters because immune deficiency, allergic bronchopulmonary aspergillosis, cystic fibrosis, primary ciliary dyskinesia and aspiration can change treatment and family advice.
  • Obtain routine bacterial and mycobacterial sputum cultures while clinically stable; the microbiological history becomes the map for future exacerbation treatment.
  • Every patient with clinically significant disease should be taught an individual airway-clearance technique by a respiratory physiotherapist and have technique and adherence reviewed.
  • Do not prescribe inhaled corticosteroids solely for bronchiectasis; use them for a separate indication such as asthma, COPD or active ABPA.
  • Vaccination, smoking cessation, exercise, nutritional assessment and pulmonary rehabilitation for limiting breathlessness are core management rather than optional extras.
  • Chronic Pseudomonas, frequent exacerbations, declining lung function, NTM, ABPA, immune deficiency or advanced disease warrants ongoing specialist follow-up.

Key red flags

Haemoptysis phenotype

Blood-streaking may accompany an exacerbation, but recurrent or substantial bleeding requires assessment for malignancy, tuberculosis, pulmonary embolism and vascular complications rather than automatic attribution to known bronchiectasis.

Investigation priorities

01
Thin-section chest CTFirst step

Confirm abnormal airway dilatation and map extent, mucus plugging and associated lung disease.

Management branches

DiagnoseConfirm a clinical-radiological syndrome

Persistent productive cough, repeated chest infection, unexplained haemoptysis or suggestive imaging.

  1. Document sputum pattern, prior pneumonia or tuberculosis, childhood and ENT history, aspiration symptoms, inflammatory disease, fertility and family history, then obtain baseline radiography and diagnostic thin-section CT.
  2. Send stable routine and mycobacterial sputum, perform the BTS core blood panel and add CF, PCD, immune, autoimmune, aspiration or AAT tests only where phenotype and guideline criteria support them.
  3. Record aetiology, lobar distribution, exacerbation and admission history, lung function, microbiology and comorbidity; use a severity score to support, not replace, clinical judgement.

Key medicines

Nebulised hypertonic saline as a mucoactive trialConcentration, volume and frequency should follow the respiratory physiotherapist's local bronchiectasis protocol after an observed airway-reactivity assessment; there is no single universal UK schedule.Can provoke cough, wheeze or bronchospasm. Demonstrate nebuliser hygiene, consider bronchodilator pre-treatment only when indicated, avoid continuing an ineffective burdensome treatment and never substitute it for taught airway clearance.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BTS Guideline for bronchiectasis in adultsUK diagnosis, aetiology, airway-clearance, microbiology, complication and follow-up framework.
  • BTS Quality Standard for clinically significant bronchiectasisService-level expectations for specialist assessment, self-management, physiotherapy and review.
  • ERS Clinical Practice Guideline for adult bronchiectasisCurrent specialist-society recommendations on airway clearance, rehabilitation and phenotype-directed long-term care.
  • NICE NG117: Bronchiectasis acute exacerbationUK antimicrobial stewardship and safety-net context linked from the companion exacerbation chapter.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom